ArticlePharmaceuticals (Basel, Switzerland)2026
Impact of Dyslipidemia on Allogeneic Transplantation Outcomes and Cardiovascular Mortality in Patients with Acute Leukemias in the Post-Transplant Cyclophosphamide Era.
Sema Seçilmiş, Burcu Aslan Candır, Uğur Hatipoğlu, Mert Seyhan, Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Dicle İskender, Merih Kızıl Çakar, Turgay Ulaş, Mehmet Sinan Dal and 1 more
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Sema SeçilmişDepartment of Hematology and Bone Marrow Transplantation Center, Etlik City Hospital, Ankara 06170, Türkiye.ORCID 0000-0003-2957-2339 Burcu Aslan CandırDepartment of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Oncology Training and Research Hospital, Ankara 06200, Türkiye.ORCID 0000-0003-3386-8984 Uğur HatipoğluDepartment of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Oncology Training and Research Hospital, Ankara 06200, Türkiye.
Mert SeyhanDepartment of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Oncology Training and Research Hospital, Ankara 06200, Türkiye.ORCID 0000-0001-5083-6306 Bahar Uncu UluDepartment of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Oncology Training and Research Hospital, Ankara 06200, Türkiye.
Tuğçe Nur YiğenoğluDepartment of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Oncology Training and Research Hospital, Ankara 06200, Türkiye.
Dicle İskenderDepartment of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Oncology Training and Research Hospital, Ankara 06200, Türkiye.
Merih Kızıl ÇakarDepartment of Hematology and Bone Marrow Transplantation Center, Etlik City Hospital, Ankara 06170, Türkiye.
Turgay UlaşDepartment of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Oncology Training and Research Hospital, Ankara 06200, Türkiye.ORCID 0000-0001-9332-663X Mehmet Sinan DalDepartment of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Oncology Training and Research Hospital, Ankara 06200, Türkiye.
Fevzi AltuntaşDepartment of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Oncology Training and Research Hospital, Ankara 06200, Türkiye.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
acute leukemiascardiovascular mortalitydyslipdemiahematopoietic stem cell transplantationpost-transplant cyclophosphamide
Identifiers
PMID42075786
PMCPMC13118544
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390